Tylenol Industry and RFK Jr. Clash Over Autism Claims
TL;DR Summary
The CEO of Kenvue, maker of Tylenol, reportedly urged RFK Jr. not to link the drug to autism, amid plans by his agency to release a report suggesting a connection between acetaminophen and autism risk, despite inconclusive scientific evidence and potential legal and reputational repercussions for the company.
- Pharma Boss Pleaded With RFK Jr. to Ditch Bogus Autism Claim The Daily Beast
- RFK Jr.’s Calls With a Scientist Who Says Kids Get Autism From Tylenol The Atlantic
- Exclusive | RFK Jr., HHS to Link Autism to Tylenol Use in Pregnancy and Folate Deficiencies The Wall Street Journal
- In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reports CNN
- Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports Reuters
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
93%
651 → 48 words
Want the full story? Read the original article
Read on The Daily Beast